The Potential sales for 2020 are exciting and would blow away analysts expectations in a reasonable scenario.
However The YOY 2019 to 2018 increases could be skewed by the results of the study.
If you take the quarterly growth rates of 2019 and apply to 2020 you get about $700 million in 2020. You would THINK the growth rates would be more from expanded label in larger population than it was from RI results but no idea really, the RI results were instantly known, while getting word out on expanded label might be slower.
I still come back to $700+50 is $750 and that would be JT sales forecast high end and on the bright side would cause increases in analysts forecasted sales BUT I agree 1 billion is magic # for street to see, so I think if JT sees it that way they will defer on 2020 sales estimates until Q1 is complete, not sure how that would play but probably safer bet than any sales projection by management under 1 billion.
As usual Amarin will be very interesting the next year